Trinity Biotech plc (TRIB) Debt by Year
Trinity Biotech plc carried $20.0M in long-term debt against $5.1M in cash and equivalents at the end of fiscal year 2025. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Trinity Biotech plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TRIB Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $20.0M | N/A | $10.9M | N/A | $13.9M+1230.6% | $1.0M0.0% | $1.0M-99.0% | $99.9M+9487.3% | $1.0M0.0% | $1.0M+104100.0% | $1K |
| Cash & Equivalents | $5.1M-0.6% | $5.2M+40.0% | $3.7M-43.9% | $6.6M-74.6% | $25.9M-5.2% | $27.3M+79.4% | $15.2M-49.7% | $30.3M-47.4% | $57.6M-25.3% | $77.1M-24.4% | $102.0M |
TRIB Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q1'2510-Q | Q3'2410-K | Q3'2310-K | Q1'2310-Q | Q3'2210-K | Q3'2110-K | Q3'2010-K | Q3'1910-K | Q1'1910-Q | Q4'1810-Q | Q3'1810-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | $10.2M | $10.9M | N/A | $12.7M | $13.9M+1230.6% | $1.0M0.0% | $1.0M-99.0% | $99.9M+9487.3% | N/A | N/A | $1.0M0.0% |
| Cash & Equivalents | $5.2M+40.0% | $5.3M | $3.7M-43.9% | $6.6M-74.6% | $10.5M | $25.9M-5.2% | $27.3M+79.4% | $15.2M-49.7% | $30.3M-47.4% | $49.4M-22.7% | $53.9M | $57.6M-25.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Trinity Biotech plc financials
Frequently Asked Questions
What was Trinity Biotech plc's long-term debt in fiscal year 2025?
Trinity Biotech plc carried $20.0M in long-term debt against $5.1M in cash and equivalents at the end of fiscal year 2025.
How has Trinity Biotech plc's long-term debt changed over the years?
Across the 11 fiscal years this page covers, Trinity Biotech plc (TRIB) long-term debt went from $1K in fiscal year 2015 to $20.0M in fiscal year 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Trinity Biotech plc (TRIB) reported on that line in every period on record.